Home › Companies › Biotechnology, Diabetes, Health Care, Medical, Therapeutics › Aerami Therapeutics
Aerami Therapeutics
Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases.
Aerami Therapeutics is active in the biotechnology, diabetes, health care, medical, therapeutics space based in Research Triangle, East Coast, Southern US, founded in 2010.
Within the biotechnology, diabetes, health care, medical, therapeutics space, the company focuses on its core offering rather than a broad product line.
Its base of operations is Research Triangle, East Coast, Southern US.
It is recorded at the Series_B stage.
The company reports a headcount in the c_00011_00050 range.
Public records show total funding of about $133.5M.
| Sector | Biotechnology, Diabetes, Health Care, Medical, Therapeutics |
|---|---|
| Headquarters | Research Triangle, East Coast, Southern US |
| Founded | 2010 |
| Employees | c_00011_00050 |
| Stage | series_b |
| Total funding | $133,544,000 |
Website: aerami.com
Browse related
Sign in to view the contact information we hold for Aerami Therapeutics.
Create a free account
Create a free account